Subject
Immunology and Allergy,Immunology,Pulmonary and Respiratory Medicine
Reference9 articles.
1. Efficacy and safety of omalizumab against chronic spontaneous urticaria: real-world study from China;Wang;World Allergy Organ J,2022
2. Omalizumab;Kumar,2023
3. Expert consensus on the use of omalizumab in chronic urticaria in China;Zhao;World Allergy Organ J,2021
4. European Medicines Agency. http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines (human/medicines/000606/human_med_001162.jsp&mid=WC0b01ac058001d124.
5. Omalizumab updosing in chronic spontaneous urticaria: an overview of real-world evidence;Metz;Clin Rev Allergy Immunol,2020
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献